We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals

47 hedge funds and large institutions have $50M invested in Tonix Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

798% more capital inflows, than outflows

Capital inflows: $27.6M | Capital outflows: $3.07M

286% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 7

74% more funds holding

Funds holding: 27 → 47 (+20)

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

11.34% more ownership

Funds ownership: 7.57% → 18.9% (+11%)

Holders
47
Holders Change
+20
Holders Change %
+74.07%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
10
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TNXP Hedge Fund Activity: Q2 2025 in Review

47 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2025, worth a combined $50M — up 486% from $8.53M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TNXP positions and 7 closed out — a net gain of 20 holders — while 10 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $9.19M. The largest seller was Royal Bank of Canada, cutting an estimated $878K.

  • 47 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2025, up from 27 in Q1 2025.
  • Funds reported $50M of Tonix Pharmaceuticals stock for Q2 2025, up 486% quarter-over-quarter.
  • 27 funds opened new Tonix Pharmaceuticals positions in Q2 2025 and 7 closed out, a net change of +20 holders.
  • The largest Tonix Pharmaceuticals buyer in Q2 2025 was BlackRock, an estimated $9.19M added.
  • The largest Tonix Pharmaceuticals seller in Q2 2025 was Royal Bank of Canada, an estimated $878K sold.

Based on aggregated 13F filings for Q2 2025.